Monday, September 24, 2018

Proof-of-concept HIV immunotherapy study passes Phase 1 safety trial

  1. Proof-of-concept HIV immunotherapy study passes Phase 1 safety trial  Science Daily
  2. First HIV immunotherapy drug proves safe in phase 1 trial  Infosurhoy
  3. Scientists close in on HIV cure  Guardian (blog)Full coverage
(CLICK HERE TO READ AND SEE MORE

0 comments:

Post a Comment